Stock SHAMROIN SHAMROCK INDUSTRIAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shamrock Industrial Company Limited

Equities

SHAMROIN

INE022F01015

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:53 13/05/2024 BST 		5-day change 1st Jan Change
12.13 INR 0.00% Intraday chart for Shamrock Industrial Company Limited 0.00% +49.20%
02-10 Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 22.14 22.14 22.14 22.14 38.46 19.96
Enterprise Value (EV) 1 68.15 -0.0535 5.566 8.713 28.44 10.29
P/E ratio -28.6 x -6.48 x -8.51 x -5.93 x -18.5 x -15.3 x
Yield - - - - - -
Capitalization / Revenue - - - 251,581,818 x 39,839,118 x -
EV / Revenue - - - 99,014,386 x 29,453,449 x -
EV / EBITDA - - - - - -
EV / FCF -207 x 0 x -1.16 x -4 x -11.1 x 97.7 x
FCF Yield -0.48% 50,422% -86.2% -25% -9.05% 1.02%
Price to Book 0.64 x 0.71 x 0.77 x 0.89 x 2.03 x 1.13 x
Nbr of stocks (in thousands) 6,436 6,436 6,436 6,436 5,425 5,425
Reference price 2 3.440 3.440 3.440 3.440 7.090 3.680
Announcement Date 05/09/18 31/08/19 30/09/20 08/09/21 28/06/22 05/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales - - - 0.088 0.9655 -
EBITDA - - - - - -
EBIT 1 -0.969 -36.55 -2.195 -3.139 -2.075 -1.278
Operating Margin - - - -3,566.72% -214.89% -
Earnings before Tax (EBT) 1 -0.6417 -2.882 -2.195 -3.139 -2.075 -1.278
Net income 1 -0.6417 -2.882 -2.195 -3.139 -2.075 -1.285
Net margin - - - -3,566.72% -214.89% -
EPS 2 -0.1203 -0.5308 -0.4044 -0.5800 -0.3822 -0.2400
Free Cash Flow 1 -0.3292 -26.99 -4.797 -2.177 -2.572 0.1052
FCF margin - - - -2,474.36% -266.42% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 05/09/18 31/08/19 30/09/20 08/09/21 28/06/22 05/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net Debt 1 46 - - - - -
Net Cash position 1 - 22.2 16.6 13.4 10 9.68
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.33 -27 -4.8 -2.18 -2.57 0.11
ROE (net income / shareholders' equity) -2.17% -10.3% -8.68% -13.9% -10.4% -7%
ROA (Net income/ Total Assets) -0.79% -42.9% -5.01% -8.49% -6.32% -4.27%
Assets 1 80.87 6.715 43.82 36.99 32.81 30.09
Book Value Per Share 2 5.390 4.860 4.460 3.880 3.500 3.260
Cash Flow per Share 2 0.0200 4.090 3.050 2.470 1.850 1.780
Capex 1 0.02 0.74 - - - -
Capex / Sales - - - - - -
Announcement Date 05/09/18 31/08/19 30/09/20 08/09/21 28/06/22 05/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SHAMROCK INDUSTRIAL COMPANY LIMITED Stock Shamrock Industrial Company Limited
+49.20% 790K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.60% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.02% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.33% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.89% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.16% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SHAMROIN Stock
  4. Financials Shamrock Industrial Company Limited